Cargando…
From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU
In 1997, the human corneal epithelium was reconstructed in vitro and transplanted on patients. Later, it became a routine treatment, before regulations considered advanced therapy medicinal products and drugs on the same lines. Manufacturing, before and after good manufacturing practice setting, was...
Autores principales: | Pellegrini, Graziella, Lambiase, Alessandro, Macaluso, Claudio, Pocobelli, Augusto, Deng, Sophie, Cavallini, Gian Maria, Esteki, Roza, Rama, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561870/ https://www.ncbi.nlm.nih.gov/pubmed/27091398 http://dx.doi.org/10.2217/rme-2015-0051 |
Ejemplares similares
-
Location and Clonal Analysis of Stem Cells and Their Differentiated Progeny in the Human Ocular Surface
por: Pellegrini, Graziella, et al.
Publicado: (1999) -
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization
por: Attico, Eustachio, et al.
Publicado: (2022) -
Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up
por: Attico, Eustachio, et al.
Publicado: (2023) -
Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU
por: Demirci, Ebru, et al.
Publicado: (2023) -
Leveraging existing opportunities for improved Orphan Drug approval in the EU
por: Edfjäll, Catarina
Publicado: (2012)